Donald W. Macglashan

Donald W. Macglashan's AcademicInfluence.com Rankings

Philosophy

#7083

World Rank

#10242

Historical Rank

Logic

#4158

World Rank

#5416

Historical Rank

philosophy Degrees

Donald W. Macglashan

Biology

#9611

World Rank

#12835

Historical Rank

Immunology

#572

World Rank

#591

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Donald W. Macglashan's Degrees

PhD Immunology University of California, San Francisco
Doctorate Medicine University of California, San Francisco

Why Is Donald W. Macglashan Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Donald W. Macglashan's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody. (1997) (794)
Omalizumab-induced reductions in mast cell FcεRI expression and function (2004) (383)
The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils. (1992) (315)
Generation of leukotrienes by purified human lung mast cells. (1982) (292)
Secretion of IL-4 from human basophils. The relationship between IL-4 mRNA and protein in resting and stimulated basophils. (1994) (287)
Prostaglandin-Induced Activation of Nociceptive Neurons via Direct Interaction with Transient Receptor Potential A1 (TRPA1) (2008) (274)
Arachidonic acid metabolism in purified human lung mast cells. (1984) (234)
Human lung mast cells: purification and characterization. (1982) (224)
Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. (1983) (217)
Down-Regulation of Human Basophil IgE and FCεRIα Surface Densities and Mediator Release by Anti-IgE-Infusions Is Reversible In Vitro and In Vivo (1999) (199)
Characteristics of human basophil sulfidopeptide leukotriene release: releasability defined as the ability of the basophil to respond to dimeric cross-links. (1986) (195)
Lipid bodies: cytoplasmic organelles important to arachidonate metabolism in macrophages and mast cells. (1983) (194)
Histamine: A mediator of inflammation. (2003) (183)
Studies of IgE-dependent histamine releasing factors: heterogeneity of IgE. (1987) (178)
IgE-dependent IL-4 secretion by human basophils. The relationship between cytokine production and histamine release in mixed leukocyte cultures. (1994) (167)
Regulation of human basophil and lung mast cell function by cyclic adenosine monophosphate. (1988) (165)
Expression of CD203c and CD63 in human basophils: relationship to differential regulation of piecemeal and anaphylactic degranulation processes (2010) (152)
Characterization of inflammatory mediator release from purified human lung mast cells. (1986) (143)
In vitro regulation of FcεRIα expression on human basophils by IgE antibody (1998) (141)
Regulation of human basophil mediator release by cytokines. I. Interaction with antiinflammatory steroids. (1989) (139)
Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement. (2008) (135)
Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy. (2012) (135)
Omalizumab-induced reductions in mast cell Fce psilon RI expression and function. (2004) (128)
Human basophils: mediator release and cytokine production. (2001) (125)
IgE antibody up-regulates high affinity IgE binding on murine bone marrow-derived mast cells. (1996) (124)
Releasability of human basophils: cellular sensitivity and maximal histamine release are independent variables. (1993) (124)
Dispersed human lung mast cells. Pharmacologic aspects and comparison with human lung tissue fragments. (1982) (122)
The gene and cDNA for the human high affinity immunoglobulin E receptor beta chain and expression of the complete human receptor. (1992) (111)
Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge. (2009) (110)
Basophil activation testing. (2013) (110)
The relationship between serum IgE and surface levels of FcϵR on human leukocytes in various diseases: Correlation of expression with FcϵRI on basophils but not on monocytes or eosinophils (2000) (110)
A comparative study of releasing and nonreleasing human basophils: nonreleasing basophils lack an early component of the signal transduction pathway that follows IgE cross-linking. (1990) (107)
Human lung macrophage-derived histamine-releasing activity is due to IgE-dependent factors. (1986) (107)
Heterogeneity of human mast cells. (1983) (106)
Inhibition of basophil histamine release by anti-inflammatory steroids. II. Studies on the mechanism of action. (1982) (104)
Comparative studies of human basophils and mast cells. (1983) (103)
Human lung macrophages induce histamine release from basophils and mast cells. (1985) (101)
Differential regulation of IL-4 and IL-13 secretion by human basophils: their relationship to histamine release in mixed leukocyte cultures. (1998) (99)
The purification of human basophils. (1980) (97)
Relationship between spleen tyrosine kinase and phosphatidylinositol 5' phosphatase expression and secretion from human basophils in the general population. (2007) (90)
IgE receptor and signal transduction in mast cells and basophils. (2008) (88)
Loss of syk kinase during IgE-mediated stimulation of human basophils. (2004) (86)
Differences in the behavior of cytoplasmic granules and lipid bodies during human lung mast cell degranulation (1984) (83)
Immunoglobulin E-mediated degranulation of isolated human lung mast cells. (1985) (82)
Preliminary identification and role of phosphodiesterase isozymes in human basophils. (1992) (82)
Monoclonal Antibodies Specific for Human IgE-Producing B Cells: A Potential Therapeutic for IgE-Mediated Allergic Diseases (1990) (81)
Leukocyte immunoglobulin-like receptors: novel innate receptors for human basophil activation and inhibition. (2004) (81)
Upregulation of FcϵRI on human basophils by IgE antibody is mediated by interaction of IgE with FcϵRI (1999) (80)
The tyrosine kinases p53/56lyn and p72syk are differentially expressed at the protein level but not at the messenger RNA level in nonreleasing human basophils. (2000) (79)
Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14-3D10. (2000) (77)
A pH-stabilizing role of voltage-gated proton channels in IgE-mediated activation of human basophils (2008) (77)
Differential Release of Mediators From Human Basophils: Differences in Arachidonic Acid Metabolism Following Activation by Unrelated Stimuli (1989) (76)
Down-regulation of human basophil IgE and FC epsilon RI alpha surface densities and mediator release by anti-IgE-infusions is reversible in vitro and in vivo. (1999) (76)
Intracellular Expression and Release of FcεRIα by Human Eosinophils (1999) (75)
Macrophage-derived chemokine induces human eosinophil chemotaxis in a CC chemokine receptor 3- and CC chemokine receptor 4-independent manner. (1999) (74)
Nasal sensory nerve populations responding to histamine and capsaicin. (2005) (73)
Single-cell analysis of Ca++ changes in human lung mast cells: graded vs. all-or-nothing elevations after IgE-mediated stimulation (1989) (72)
Studies of antigen binding on human basophils. I. Antigen binding and functional consequences. (1983) (70)
Signal transduction events in human basophils. A comparative study of the role of protein kinase C in basophils activated by anti-IgE antibody and formyl-methionyl-leucyl-phenylalanine. (1990) (69)
Flow cytometric methods for the analysis of human basophil surface antigens and viability. (1989) (66)
Extracellular signal-regulated kinases regulate leukotriene C4 generation, but not histamine release or IL-4 production from human basophils. (1999) (64)
Serum IgE level drives basophil and mast cell IgE receptor display. (1997) (62)
Role of chloride channels in bradykinin‐induced guinea pig airway vagal C‐fibre activation (2005) (62)
Studies of antigen binding on human basophils. II. Continued expression of antigen-specific IgE during antigen-induced desensitization. (1983) (62)
Phosphatidylinositol-3 kinase regulates p21ras activation during IgE-mediated stimulation of human basophils. (2000) (61)
How IgE upregulates the allergic response. (2002) (60)
Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation. (2013) (59)
Biphasic Ca2+ responses in human basophils. Evidence that the initial transient elevation associated with the mobilization of intracellular calcium is an insufficient signal for degranulation. (1993) (58)
The effect of pertussis toxin on mediator release from human basophils. (1987) (58)
Protein kinase C (PKC) changes in human basophils. IgE-mediated activation is accompanied by an increase in total PKC activity. (1989) (58)
The concept of basophil releasibility (1986) (56)
Differences in Functional Consequences and Signal Transduction Induced by IL-3, IL-5, and Nerve Growth Factor in Human Basophils1 (2001) (56)
Endocytosis, recycling, and degradation of unoccupied FcεRI in human basophils (2007) (54)
In vitro regulation of FcepsilonRIalpha expression on human basophils by IgE antibody. (1998) (54)
Expression and modulation of Fc?RIa and Fc?RI in human blood basophils (2001) (53)
Regulation of Syk kinase and FcRbeta expression in human basophils during treatment with omalizumab. (2010) (53)
Inflammatory mediators and mechanisms of release from purified human basophils and mast cells. (1984) (53)
Expression of functional cysteinyl leukotriene receptors by human basophils. (2005) (52)
Purified human mast cells and basophils release human elastase and cathepsin G by an IgE-mediated mechanism. (1985) (51)
Inhibition of IgE-mediated secretion from human basophils with a highly selective Bruton's tyrosine kinase, Btk, inhibitor. (2011) (51)
IgE-dependent regulation of human basophil adherence to vascular endothelium. (1989) (51)
Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors. (2012) (50)
The transition from specific to nonspecific desensitization in human basophils. (1981) (49)
The modulation of human basophil histamine release by products of the 5-lipoxygenase pathway. (1982) (48)
The human recombinant histamine releasing factor: functional evidence that it does not bind to the IgE molecule. (1999) (48)
GM-CSF regulates human eosinophil responses to F-Met peptide and platelet activating factor. (1993) (47)
Regulation of IgE-dependent IL-4 generation by human basophils treated with glucocorticoids. (1997) (47)
Immunoglobulin E-mediated release of a kininogenase from purified human lung mast cells. (1985) (46)
Oscillations in free cytosolic calcium during IgE-mediated stimulation distinguish human basophils from human mast cells. (1991) (46)
IL-3 alters free arachidonic acid generation in C5a-stimulated human basophils. (1993) (46)
Loss of receptors and IgE in vivo during treatment with anti-IgE antibody. (2004) (45)
New concepts: the basophil. (1997) (44)
F-met peptide-induced degranulation of human basophils. (1991) (43)
The mechanism of mediator release from human basophils induced by platelet-activating factor. (1990) (43)
The pharmacologic modulation of the release of arachidonic acid metabolites from purified human lung mast cells. (1985) (43)
Dual Phase Priming by IL-3 for Leukotriene C4 Generation in Human Basophils: Difference in Characteristics Between Acute and Late Priming Effects1 (2000) (42)
A rapid Percoll technique for the purification of human basophils. (1987) (41)
Distinct characteristics of signal transduction events by histamine-releasing factor/translationally controlled tumor protein (HRF/TCTP)-induced priming and activation of human basophils. (2008) (41)
Functional consequences of FcɛRIα up‐regulation by IgE in human basophils (2000) (41)
Effect of prostaglandin D2 in modulating histamine release from human basophils. (1984) (41)
Graded changes in the response of individual human basophils to stimulation: distributional behavior of events temporally coincident with degranulation (1995) (40)
Expression of protein kinase C isozymes in human basophils: regulation by physiological and nonphysiological stimuli. (1998) (40)
Intracellular expression and release of Fc epsilon RI alpha by human eosinophils. (1999) (39)
Counter-receptors on human basophils for endothelial cell adhesion molecules. (1996) (39)
The relationship between serum IgE and surface levels of FcepsilonR on human leukocytes in various diseases: correlation of expression with FcepsilonRI on basophils but not on monocytes or eosinophils. (2000) (38)
Test of a theory relating to the cross-linking of IgE antibody on the surface of human basophils. (1985) (38)
Synthetic IgE peptide vaccine for immunotherapy of allergy. (2003) (37)
IgE-regulated loss, not IgE-regulated synthesis, controls expression of FcepsilonRI in human basophils. (2001) (37)
Nonspecific Desensitization, Functional Memory, and the Characteristics of SHIP Phosphorylation following IgE-Mediated Stimulation of Human Basophils1 (2006) (37)
IL‐4 secretion and histamine release by human basophils are differentially regulated by protein kinase C activation (1998) (37)
Inducing an anergic state in mast cells and basophils without secretion. (2008) (36)
Immobilized glucuronosyltransferase for the synthesis of conjugates. (1976) (36)
Activated human basophils contain histamine in cytoplasmic vesicles. (1994) (35)
Marked differences in the signaling requirements for expression of CD203c and CD11b versus CD63 expression and histamine release in human basophils. (2012) (34)
Basic characteristics of human lung mast cell desensitization. (1987) (34)
Subthreshold desensitization of human basophils re‐capitulates the loss of Syk and FcεRI expression characterized by other methods of desensitization (2012) (34)
Lipid Bodies: Widely Distributed Cytoplasmic Structures That Represent Preferential Nonmembrane Repositories of Exogenous [3H]Arachidonic Acid Incorporated by Mast Cells, Macrophages, and Other Cell Types (1985) (34)
Two Regions of Down-Regulation in the IgE-Mediated Signaling Pathway in Human Basophils1 (2003) (34)
Qualitative differences between dimeric and trimeric stimulation of human basophils. (1983) (34)
Quantitation of 1-stearoyl-2-arachidonoyl-sn-3-glycerol in human basophils via gas chromatography-negative ion chemical ionization mass spectrometry. (1996) (33)
Mediator release from human basophils and mast cells from lung and intestinal mucosa. (1985) (33)
Localizing a Control Region in the Pathway to Leukotriene C4 Secretion Following Stimulation of Human Basophils with Anti-IgE Antibody1 (2001) (33)
The concept of basophil releasability. (1986) (32)
Glycomic analysis of human mast cells, eosinophils and basophils (2011) (32)
IgE-mediated desensitization in human basophils and mast cells. (1998) (32)
Role of receptor aggregation in triggering IgE-mediated reactions. (1982) (32)
Acute IL-3 Priming Up-Regulates the Stimulus-Induced Raf-1-Mek-Erk Cascade Independently of IL-3-Induced Activation of Erk1 (2005) (32)
Characteristics of arachidonic acid generation in human basophils: relationship between the effects of inhibitors of secretory phospholipase A2 activity and leukotriene C4 release. (1998) (32)
Induced Loss of Syk in Human Basophils by Non-IgE-Dependent Stimuli (2008) (31)
Piceatannol is an effective inhibitor of IgE‐mediated secretion from human basophils but is neither selective for this receptor nor acts on syk kinase at concentrations where mediator release inhibition occurs (2001) (31)
An antigen-activated DFP-inhibitable enzyme controls basophil desensitization. (1984) (30)
Vesicular transport of histamine in stimulated human basophils. (1996) (30)
Pharmacology of IgE-mediated desensitization of human basophils: effects of protein kinase C and src-family kinase inhibitors. (2000) (30)
Upregulation of FcepsilonRI on human basophils by IgE antibody is mediated by interaction of IgE with FcepsilonRI. (1999) (29)
Early signal protein expression profiles in basophils: a population study (2009) (29)
Autoantibodies to IgE and Fc&egr;RI and the natural variability of spleen tyrosine kinase expression in basophils (2019) (29)
Phosphorylation of cytosolic phospholipase A2 by IL-3 is associated with increased free arachidonic acid generation and leukotriene C4 release in human basophils. (1998) (29)
Cytokine generation by human basophils. (1994) (28)
Characterization of syk expression in human lung mast cells: relationship with function (2011) (27)
Endocytosis, recycling, and degradation of unoccupied FcepsilonRI in human basophils. (2007) (27)
An ultrastructural analysis of tumor-promoting phorbol diester-induced degranulation of human basophils. (1992) (26)
Syk expression in peripheral blood leukocytes, CD34+ progenitors, and CD34‐derived basophils (2010) (26)
Purified human basophils and mast cells: current concepts of mediator release. (1983) (26)
Graded changes in the response of individual human basophils to stimulation: distributional behavior of early activation events (1994) (26)
Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition. (1991) (25)
Pharmacologic regulation of histamine release by the human recombinant histamine-releasing factor. (1999) (25)
Histamine distribution in human basophil secretory granules undergoing FMLP-stimulated secretion and recovery. (1995) (24)
Human mast cells and basophils-structure, function, pharmacology, and biochemistry (1983) (24)
Transient transfection of human peripheral blood basophils. (2005) (24)
Differential effects of cAMP‐elevating drugs on stimulus‐induced cytosolic calcium changes in human basophils (1994) (24)
Function and expression of adhesion molecules on human basophils. (1994) (24)
Therapeutic efficacy of omalizumab. (2009) (23)
Regulation of IgE‐mediated signalling in human basophils by CD32b and its role in Syk down‐regulation (2014) (23)
Vesicular transport of histamine in stimulated human basophils (1996) (23)
Purified human basophils do not generate LTB4. (1987) (22)
Updates on cells and cytokines (1997) (22)
Expression of the high affinity IgE receptor by neutrophils of individuals with allergic asthma is both minimal and insensitive to regulation by serum IgE. (2009) (22)
Pharmacologic and biochemical studies of human lung mast cells (MC) (1982) (21)
Studies of the intracellular Ca2+ levels in human adult skin mast cells activated by the ligand for the human c-kit receptor and anti-IgE. (1994) (21)
Mechanisms of mediator release from human skin mast cells upon stimulation by the bradykinin analog, [DArg0-Hyp3-DPhe7]bradykinin. (1991) (20)
IgE and FcepsilonRI regulation. (2005) (20)
Parameters determining the efficacy of CD32 to inhibit activation of FcεRI in human basophils. (2016) (20)
The heterogeneity of human IgE exemplified by the passive transfer of D2O sensitivity (1991) (20)
Self-termination/anergic mechanisms in human basophils and mast cells. (2009) (19)
Transfectomas expressing both secreted and membrane-bound forms of chimeric IgE with anti-viral specificity. (1991) (19)
Syk expression and IgE‐mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab (2017) (19)
Histamine-containing cells in human peritoneal fluid. (1984) (18)
Expression Profiling of Human Basophils: Modulation by Cytokines and Secretagogues (2015) (18)
Characteristics of the free cytosolic calcium timelag following IgE‐mediated stimulation of human basophils: significance for the nonreleasing basophil phenotype (2001) (18)
The pathophysiology of human mast cells. In vitro and in vivo function. (1987) (17)
The interaction of cytokines with human basophils and mast cells. (1995) (17)
Studies of cell adhesion and flow cytometric analyses of degranulation, surface phenotype, and viability using human eosinophils, basophils, and mast cells. (1997) (16)
Comparative ultrastructural morphology of human basophils stimulated to release histamine by anti-IgE, recombinant IgE-dependent histamine-releasing factor, or monocyte chemotactic protein-1. (1996) (16)
Vesicular transport of Charcot-Leyden crystal protein in tumor-promoting phorbol diester-stimulated human basophils. (1996) (16)
IgE and Fc{epsilon}RI regulation. (2005) (16)
The pharmacologic control of mediator release from human basophils and mast cells. (1986) (16)
Bradykinin is a potent and relatively selective stimulus for cytosolic calcium elevation in human synovial cells. (1994) (16)
Response of Peripheral Blood Basophils in Subjects with Chronic Spontaneous Urticaria During Treatment with Omalizumab. (2021) (15)
Vesicular transport of Charcot-Leyden crystal protein in f-Met peptide-stimulated human basophils. (1997) (15)
Effect of okadaic acid on human basophil secretion. (1993) (14)
Effects of a specific inhibitor of the 5-lipoxygenase pathway on mediator release from human basophils and mast cells. (1988) (14)
Lectins do not distinguish between heterogenous IgE molecules as defined by differential activity of an IgE-dependent histamine releasing factor. (1996) (14)
Persistence of early crosslink-dependent signal transduction events in human basophils after desensitization. (1988) (14)
Immunogold probe for the light-microscopic phenotyping of human mast cells and basophils. (1987) (14)
Expression and modulation of FcepsilonRIalpha and FcepsilonRIbeta in human blood basophils. (2001) (14)
Signal transduction and cytokine production by human basophils. (1995) (14)
Surface plasmon resonance analysis of free IgE in allergic patients receiving omalizumab (Xolair). (2012) (13)
Targeting the FcεRI Pathway as a Potential Strategy to Prevent Food-Induced Anaphylaxis (2020) (13)
Actin cytoskeleton‐dependent down‐regulation of early IgE‐mediated signaling in human basophils (2004) (13)
The pharmacologic modulation of mediator release from human basophils. (1988) (13)
Polymerization of actin does not regulate desensitization in human basophils (2009) (13)
Release of elastase from purified human lung mast cells and basophils (1989) (12)
The Efficacy of Omalizumab Treatment in Chronic Spontaneous Urticaria is Associated with Basophil Phenotypes. (2021) (12)
Assessing basophil functional measures during monoclonal anti-IgE therapy. (2012) (12)
Cat allergen‐induced blood basophil reactivity in vitro predicts acute human nasal allergen challenge responses in vivo (2011) (11)
The role of prostaglandin D2 in IgE-mediated reactions in man. (1982) (10)
Functional consequences of FcepsilonRIalpha up-regulation by IgE in human basophils. (2000) (10)
Recovery of human basophils after FMLP‐stimulated secretion (1996) (10)
Granulocytes: New roles for basophils (2008) (9)
Effector Cells of Allergy (2006) (9)
Signal transduction: mechanisms in basophils. (1994) (9)
Maitotoxin, a novel activator of mediator release from human basophils, induces large increases in cytosolic calcium resulting in histamine, but not leukotriene C4, release. (1992) (9)
Spontaneous basophil responses in food-allergic children are transferable by plasma and are IgE-dependent. (2013) (9)
FceRI density and spontaneous secretion from human basophils (2017) (8)
Localization of Charcot‐Leyden crystal protein in individual morphological phenotypes of human basophils stimulated by f‐Met peptide (1997) (8)
Stimulation of the high-affinity IgE receptor results in the tyrosine phosphorylation of a 60 kD protein which is associated with the protein-tyrosine kinase, Csk. (1998) (8)
Studies with purified human basophils and mast cells. (1983) (8)
Recovery from desensitization of IgE‐dependent responses in human lung mast cells (2017) (8)
Regulation of FcεRI Expression during Murine Basophil Maturation: The Interplay between IgE, Cell Division, and FcεRI Synthetic Rate (2009) (8)
Biochemical Events in Basophil/Mast Cell Activation and Mediator Release (2009) (7)
The Role of Basophil—Cytokine Networks in Asthma (1998) (7)
Human Basophils and Mast Cells. (1999) (7)
Increases in cytosolic Ca2+ accompany basophil activation by eosinophil granule major basic protein. (1997) (7)
Relationship of IgE to basophil phenotypes in peanut-sensitized adults. (2014) (7)
Development of a microarray-based method to detect exposure of human basophils to IL-3. (2012) (7)
Signal Transduction and Cytokine Production by Human Basophils (Part 1 of 2) (1995) (6)
Short‐wave infrared camera as a novel solution to allergy skin testing (2020) (6)
IgE-mediated release of inflammatory mediators from human basophils and mast cells in vitro and in vivo (1984) (6)
Mediator Release: Studies with Purified Human Basophils and Mast Cells (1983) (6)
In Vitro and In Vivo Model Systems for the Study of Allergic and Inflammatory Disorders in Man : Implications for the Pathogenesis of Asthma (1985) (6)
Anti-IgE antibody therapy. (2002) (6)
Modulation of kinin responses in human synovium by interleukin-1. (1992) (6)
Single cell analysis of free cytosolic calcium changes in human lung mast cells--II. The relationship between desensitization and the cellular regulation of calcium changes. (1991) (5)
Iconography : Autoantibodies to IgE and Fc?RI and the natural variability of spleen tyrosine kinase expression in basophils (2018) (5)
Dimeric IgE may not represent the unit signal for the release of all mediators in human basophils (1984) (5)
Signal mechanisms in the activation of basophils and mast cells. (1992) (5)
Purification of Basophilic Leukocytes from Guinea Pig and Human Blood and from Guinea Pig Bone Marrow (1982) (5)
133 Dexamethasone (DEX) selectively inhibits IL-3 priming of basophil, C5a responses (1991) (4)
Identifying Regulatory Pathways of SYK Expression in Human Basophils. (2020) (4)
Human Basophil Phenotypes and the Associated Signaling Mechanisms (2010) (4)
Stability of Syk protein and mRNA in human peripheral blood basophils (2016) (4)
Facilitated dissociation of IgE versus cell replacement. (2015) (4)
Desensitization of IL-4 secretion from mouse bone marrow-derived mast cells. (1994) (3)
Mediator Release from Basophils and Mast Cells and Its Relationship to FcRI Expression and IgE-Suppressing Therapies (2002) (3)
Preliminary characterization of diacylglycerol generation in human basophils: temporal relationship to histamine release and resolution of degranulation (1997) (3)
Mast cells and mast cell mediators in models of airway disease. (1985) (3)
Differences in effects of omalizumab on late-phase responses to allergen challenge in the skin and nose at the time of basophil hyporesponsiveness. (2014) (3)
Effect of Recombinant Human c-kit Receptor Ligand on Mediator Release from Human Skin Mast Cells. (1992) (3)
IgE-mediated leukotriene release in vitro and in vivo. (1984) (3)
403 Differential modulation of mediator release in human basophils (1991) (3)
Short Wave Infrared (SWIR) Camera As a Novel Approach to Allergy Skin Testing (2017) (3)
Modulating the Human Basophil Phenotype During Its Development and Maturation: Basophils Derived from In Vitro Cultures of CD34+ Progenitor Cells. (2020) (2)
Effects of glucocorticoids on mediator release from human basophils and mast cells (1982) (2)
Vancomycin immediate skin responses in vancomycin‐naïve subjects (2021) (2)
337 Human recombinant IgE-dependent histamine releasing factor (HrHRF) primes basophils for histamine release (1996) (2)
Basophils in Anaphylaxis (2011) (2)
THE ROLE OF LIPOXYGENASE PRODUCTS OF ARACHIDONIC ACID IN INFLAMMATORY EVENTS MEDIATED BY HUMAN BASOPHILS AND MAST CELLS (1983) (2)
Histamine release from human basophils is induced by IgE-dependent factor(s) derived from human lung macrophages and an Fc epsilon receptor-positive human B cell line. (1985) (2)
Dispersed Human Lung Mast Cells (2015) (2)
Dynamics of platelet-activating-factor release and uptake in a human neutrophil suspension. (1991) (2)
Blocking antibodies in immunotherapy: Quality versus quantity (2019) (2)
Heterogeneity of human Fc epsilon RI-bearing cells. (1989) (2)
Changes in the FcɛRIβ: FcɛRIα Ratio During Treatment with Omalizumab (2009) (2)
/sup 3/H arachidonic acid incorporation and metabolism in purified human basophils (1986) (1)
Heterogeneity of Human FcϵRI‐Bearing Cells (2007) (1)
327 Expression of calcium-dependent and independent PKC isozymes in human basophils (HB) (1996) (1)
Kinetics of Syk Expression in Human Basophils (HB) Differentiating from CD34+ Progenitors (2008) (1)
Early decrease in basophil sensitivity to Ara h 2 precedes sustained  unresponsiveness after peanut oral immunotherapy. (2019) (1)
Signaling in Human Basophils (1998) (1)
Kinetic Profiling of Clinical Symptoms and Basophil Parameters During Treatment of Chronic Spontaneous Urticaria with Omalizumab: 146 (2019) (1)
Lipoxygenase Products of Arachidonic Acid: their Role in Inflammatory Events Mediated by Human Basophils and Mast Cells (1983) (1)
Simultaneous initiation of degranulation and inhibition of leukotriene release by soman in human basophils. (1995) (1)
408 The effects of 1-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) and 1-acyl-2-acetyl-sn-glycero-3-phosphocholine (AAPC) on human basophil mediator release (1991) (1)
Human Basophils Histamine Release or IL-4 Production from Not Regulate Leukotriene C4 Generation, But Extracellular Signal-Regulated Kinases (1999) (0)
Characterization of chemokine responses in purified human basophils (2002) (0)
In lasting tribute: Lawrence M. Lichtenstein, May 31, 1934, to August 5, 2022 (2022) (0)
The protein-tyrosine kinase csk is involved in signaling through the FceRI (1996) (0)
Contents, Vol. 113, 1997 (1997) (0)
534 IgE-dependent and independent regulation of human basophil adhesiveness (1988) (0)
Non-IgE-Dependent Stimuli Induced Loss of Syk in Human Basophils (2008) (0)
Diacyglycerol (DAG) elevations in stimulated human basophils (HB) (1996) (0)
Design of a Wideband Tunnel Diode Preamplifier for Phased Array RADARs (1962) (0)
Signaling effects induced by human recombinant histamine releasing factor (HrHRF) in basophils with the hyperreleasable phenotype (2005) (0)
Differences in the Behavior Lipid Bodies during Human of Cytoplasmic Granules and Lung Mast Cell Degranulation (2003) (0)
Contents, Vol. 99, 1992 (1992) (0)
Average affinity of IgE antibody determines the concentration of antigen required for optimal histamine release from human basophils (1985) (0)
IgE interacts with FcεRI to induce FcεRI up-reglation on Human Basophils (HB) (1998) (0)
Inducing an Anergic State in Human Mast Cells (MC) and Basophils (HB) without Secretion (2008) (0)
Stimulation of Human Basophils Phosphorylation following IgE-Mediated Memory , and the Characteristics of SHIP Nonspecific Desensitization , Functional (2006) (0)
The Effects of Omalizumab on the Late-Phase Response to Nasal Allergen Challenge (2011) (0)
Omalizumab In Peanut Allergy: Effects On The Basophil, Mast Cell, And Food Challenge Response (2011) (0)
Atopic allergy and other hypersensitivities. (1990) (0)
342 Csk associates directly with GAP-associated protein p60 upon FcεRI stimulation (1996) (0)
IgE-mediated signaling in human basophils (2004) (0)
Allergen-stimulated production of intracellular ROS in neutrophils: Yes but questions remain (2011) (0)
Expression of the human basophil (BASO) activation marker, CD63, may reflect the extent of degranulation by the AND (anaphylactic degranulation) mechanism. (86.24) (2010) (0)
Leukocyte Cultures Relationship to Histamine Release in Mixed Secretion by Human Basophils: Their Differential Regulation of IL-4 and IL-13 (1998) (0)
Kinetic Profiling of Clinical Symptom Reduction Relative to Cellular Parameters During Treatment of Chronic Spontaneous Urticaria with Omalizumab (2020) (0)
The Pathophysiology of Human Mast Cells (2015) (0)
SOLID STATE AMPLIFIER TECHNIQUES. (1963) (0)
Signal Transduction and Cytokine Production by Human Basophils (Part 2 of 2) (1995) (0)
Development of a Biomarker of Pre-existing IgE Crosslinking on Human Basophils (2018) (0)
Reguation of FcεRI Expression During Murine Basophil Maturation: The Interplay Between IgE, Cell Division and FcεRI Synthetic Rate (2010) (0)
Bruton’s tyrosine kinase inhibition for the prevention of anaphylaxis: an open-label, phase 2 trial (2023) (0)
The relationship between total cellular content of CD203c and cell surface expression on human basophils (2015) (0)
Re-Defining a Dose-Response Curve for Vancomycin Skin Responses in Subjects Without a Prior Exposure to Vancomycin (2020) (0)
Changes in syk expression in human basophils (HB) induced by a non-IgE-dependent receptor, LIR7 (38.9) (2007) (0)
Contents, vol. 50, Supplement 2, 1986 (1986) (0)
Erk Independently of IL-3-Induced Activation of Stimulus-Induced Raf-1-Mek-Erk Cascade Acute IL-3 Priming UpRegulates the MacGlashan (2005) (0)
522 Relationship between FceRIa and FceRI levels in human basophils (2000) (0)
Modulation of basophil function by leukocyte immunoglobulin-like receptors (LIRs) (2003) (0)
Late Priming Effects Difference in Characteristics Between Acute Generation in Human Basophils : 4 C Dual Phase Priming by IL-3 for Leukotriene (2000) (0)
From Molecular Science to the Treatment of Allergy (1999) (0)
The relationship between released soluble FceRI-alpha and its cell surface density on human basophils (2021) (0)
Regulation of Secretion in Human Basophils (1999) (0)
The Effects of Omalizumab on the Late-Phase Response to Nasal and Skin Allergen Challenge (2012) (0)
The Metabolism of Arachidonic Acid by Purified Human Lung Mast Ceils (1985) (0)
Exploring the Impact of Basophil Surface IgE Density on Histamine Release Curve in Response to Anti-IgE (2015) (0)
Development of mRNA signatures tools to detect in vivo basophil phenotypes: IL-3 signatures (57.5) (2012) (0)
Studies of IgE receptor (FceRI) processing in human basophils (HB) (38.7) (2007) (0)
Dissociation Between Neutrophil Expression of the High Affinity IgE Receptor and Serum IgE Levels in Individuals with Allergic Asthma (2009) (0)
Molecular parameters influencing receptor crosslinking and histamine release in human basophils (1986) (0)
General discussion III (2004) (0)
Subject Index, Vol. 113, 1997 (1997) (0)
Use of Biomarker Based on Human Basophil Syk Expression to Predict the Clinical Efficacy of Omalizumab Treatment in Allergic Asthmatics (2017) (0)

This paper list is powered by the following services:

Donald W. Macglashan's Academic­Influence.com Rankings

Donald W. Macglashan's Degrees

Why Is Donald W. Macglashan Influential?

Donald W. Macglashan's Published Works

Published Works

Donald W. Macglashan's AcademicInfluence.com Rankings